Vivodyne Secures $38M for AI-Powered Drug Discovery Platform
Vivodyne, a biotech company that accelerates AI-powered drug discovery by testing therapies on lab-grown human organs raises $38M
Source: hitconsultant.net
Dan Huh News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dan Huh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dan Huh Today - Breaking & Trending Today
Khosla Ventures Bets on Growing Human Tissues to Test New Therapies with Vivodyne Investment
Philadelphia-based Vivodyne is growing human tissues in the lab to test potential new therapies before they go to clinical trials. The company was founded in 2021 at the University of Pennsylvania by Bioengineering PhD Andrei Georgescu and Associate Professor of Bioengineering Dan Huh. Vivodyne’s platform was originally developed at Penn in the BIOLines Laboratory. Vivodyne…
Source: swfinstitute.org
This Startup Raised $38 Million To Fill One Of The Biggest Gaps In Drug Discovery
Khosla Ventures-backed Vivodyne is growing human tissues in the lab to test potential new therapies before they go to clinical trials.
Source: forbes.com
Vivodyne Raises $38M in Seed Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Vivodyne Announces $38 Million Seed Financing Led by Khosla Ventures to Develop Lab-Grown Human Organs
Vivodyne, a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs, today announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos Ventures, CS...
Source: lelezard.com